<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00894309</url>
  </required_header>
  <id_info>
    <org_study_id>FRI-1</org_study_id>
    <nct_id>NCT00894309</nct_id>
  </id_info>
  <brief_title>Validation of the Fluid Responsiveness Index in Critically Ill Patients</brief_title>
  <acronym>FRI</acronym>
  <official_title>Evaluation of the Validity of a New Index Provided by the PiCCO2 Device for Predicting Fluid Responsiveness in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bicetre Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bicetre Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluid therapy is an important part of the management of patients with hemodynamic instability&#xD;
      in the intensive care unit. By increasing cardiac preload, it aims at elevating cardiac&#xD;
      output (CO) and thus restoring hemodynamic conditions in patients who are preload responsive.&#xD;
      By contrast, volume administration can be deleterious in terms of pulmonary edema formation&#xD;
      or other manifestations or fluid overload, especially in patients who are not preload&#xD;
      responsive. Functional dynamic parameters that use heart-lung interactions, such as pulse&#xD;
      pressure variation (PPV) and stroke volume variation (SVV) are considered accurate predictors&#xD;
      of preload responsiveness in patients receiving fully controlled mechanical ventilation.&#xD;
&#xD;
      However, in cases of spontaneous breathing activity where heart-lung interaction indices fail&#xD;
      to predict fluid responsiveness, one needs parameters able to reliably predict the&#xD;
      hemodynamic response of fluid administration.&#xD;
&#xD;
      A new index that could indicate fluid responsiveness, so-called the fluid responsiveness&#xD;
      index (FRI), has been elaborated. The advantage is that it could be used in patients who are&#xD;
      not in control mechanical ventilation as well as in patients who are fully adapted to&#xD;
      mechanical ventilation.&#xD;
&#xD;
      The FRI is based upon the analysis of continuous arterial and continuous central venous&#xD;
      pressure. The FRI is determined by the relation of cardiac and respiratory activity; both are&#xD;
      evaluated by means of power spectrum analysis of the pressures recorded.&#xD;
&#xD;
      The aim of this study is to test the value of the FRI to predict the hemodynamic response to&#xD;
      fluid infusion in patients with hemodynamic instability not receiving fully controlled&#xD;
      mechanical ventilation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2009</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Shock</condition>
  <condition>Critically Ill</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with an acute circulatory failure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Hospitalization in an intensive care unit&#xD;
&#xD;
          -  Presence of an acute circulatory failure as defined by the presence of at least one&#xD;
             clinical sign of inadequate global perfusion&#xD;
&#xD;
          -  Decision by the attending physician to give fluids will not be taken upon criteria&#xD;
             predefined by the study protocol but considers:&#xD;
&#xD;
               -  systolic arterial pressure &lt; 90 mmHg (or fall of systolic arterial pressure of&#xD;
                  more than 50 mmHg in known hypertensive patients)&#xD;
&#xD;
               -  urinary flow &lt; 0.5 ml/kg/hr than two hours&#xD;
&#xD;
               -  tachycardia ≥ 100 beats/min&#xD;
&#xD;
               -  delayed capillary refill&#xD;
&#xD;
               -  mottled skin&#xD;
&#xD;
               -  high lactate&#xD;
&#xD;
               -  CO (Cardiac Output) that is not considered adequate and&#xD;
&#xD;
               -  low GEDV (Global EndDiastolic Volume)&#xD;
&#xD;
          -  Monitoring by a PiCCO2™ device (Pulsion Medical Systems, Munich, Germany) already in&#xD;
             place as part of the routine hemodynamic monitoring&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinical evidence of pulmonary edema, hypervolemia or ELWI &gt; 10 ml/kg&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Monnet, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Intensive Care Unit - Bicêtre Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Azriel Perel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Intensive Care Sheba Medical Centre Tel Aviv</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Louis Teboul, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Intensive Care Unit - Bicêtre Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Reuter, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinik Eppendorf, Hamburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wolfgang Huber, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>II. Med. Klinik, Station 2/11, Munich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernando Suarez Sipmann, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unidad de cuidados intensivos, Fundacion Jimenez Diaz, Madrid</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Louis Teboul, MD, PhD</last_name>
    <phone>+33145213547</phone>
    <email>jean-louis.teboul@bct.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical Intensive Care Unit</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Xavier Monnet, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Xavier Monnet, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Daniel Reuter, MD, PhD</last_name>
      <email>dreuter@uke.uni-hamburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Rechts der Isar</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Wolfgang Huber, MD, PhD</last_name>
      <email>wolfgg.huber@t-online.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive Care Sheba Medical Centre</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Azriel Perel, MD, PhD</last_name>
      <phone>+972526667200</phone>
      <email>perelao@shani.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Unidad de cuidados intensivos, Fundacion Jimenez Diaz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Fernando Suarez Sipmann, MD, PhD</last_name>
      <email>FSuarez@fjd.es</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <study_first_submitted>May 5, 2009</study_first_submitted>
  <study_first_submitted_qc>May 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2009</study_first_posted>
  <last_update_submitted>May 5, 2009</last_update_submitted>
  <last_update_submitted_qc>May 5, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof Jean-Louis TEBOUL</name_title>
    <organization>Medical Intensive Care Unit - Bicêtre Hospital</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

